MARKET

GERN

GERN

Geron
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.360
-0.040
-2.86%
After Hours: 1.360 0 0.00% 18:33 01/24 EST
OPEN
1.400
PREV CLOSE
1.400
HIGH
1.400
LOW
1.350
VOLUME
1.27M
TURNOVER
--
52 WEEK HIGH
2.140
52 WEEK LOW
1.010
MARKET CAP
271.70M
P/E (TTM)
-5.4465
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GERN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GERN News

  • CLASS ACTION UPDATE for FSCT, PRU and GERN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  • ACCESSWIRE.3h ago
  • HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Geron Corporation (GERN) Who Have Suffered Significant Losses to Contact its Attorneys: Securities Fraud Case Filed
  • PR Newswire.23h ago
  • Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)
  • GlobeNewswire.1d ago
  • SHAREHOLDER ALERT: FSCT QD GERN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  • ACCESSWIRE.1d ago

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About GERN

Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company is engaged in the development of therapeutic products for oncology. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Janssen is engaged in the development of Imetelstat with two clinical trials, such as a Phase II trial in myelofibrosis (MF), referred to as IMbark, and a Phase II/III trial in myelodysplastic syndromes (MDS) referred to as IMerge. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the RNA template of telomerase, thereby directly inhibiting telomerase activity.
More

Webull offers Geron Corporation (GERN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.